
Epithalon
COA published
A synthetic tetrapeptide studied in telomere-biology and cellular-senescence research.

A coenzyme studied in cellular-energetics, redox-balance and sirtuin-pathway research.
Select size
Quantity
Total
$40.00
That's the price. No inflated list, no permanent “discount” code to make it look cheaper than it is.
Batch J_0726-01-NAD1000 · Certificate of Analysis available
For Research Use Only. Not for Human Consumption.
Products supplied by Synthrex Biotech LLC are intended strictly for in-vitro laboratory research and development by qualified professionals. They are not drugs, foods, cosmetics, or dietary supplements, and are not approved by the FDA for human or veterinary use. They are not sold for, and must not be used for, human or animal consumption or administration of any kind. Synthrex Biotech LLC is not a compounding pharmacy or chemical compounding facility as defined under section 503A of the Federal Food, Drug, and Cosmetic Act, and is not an outsourcing facility as defined under section 503B of that Act. By purchasing, you affirm that you are a qualified researcher acquiring these materials for lawful research purposes only. A Safety Data Sheet (SDS/MSDS) is available on request for every compound.
Sold by Synthrex Biotech LLC. A Safety Data Sheet (SDS) is available on request at support@synthrexbiotech.com.
NAD+ is not a peptide at all — it is nicotinamide adenine dinucleotide, a coenzyme present in every living cell, and one of the oldest molecules in biochemistry. It was first identified by Arthur Harden and William Young in 1906 as a heat-stable fraction required for yeast fermentation. Its structure was determined by Hans von Euler-Chelpin, and Otto Warburg later established its role in hydride transfer. The modern interest in NAD+ dates to the discovery that sirtuins — a family of protein deacetylases — consume NAD+ as a substrate, which linked cellular NAD+ availability to a regulatory system rather than just to metabolism.
NAD+ functions as an electron carrier in redox reactions and as a consumed substrate for three enzyme families: sirtuins, PARPs, and CD38/cADPR synthases. Because those enzymes cleave rather than recycle it, their activity depletes the cellular pool — the mechanistic basis for the research interest in NAD+ availability. The two review articles cited below, in Trends in Cell Biology and Science, are the standard entry points to that literature. Supplied as a laboratory research material.
These notes are provided for scientific context only. They describe published laboratory and preclinical research and are not a claim of any effect in humans. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Batch releases & restocks
We publish an independent certificate for every lot before it ships. Join the Lab List and we'll tell you when a new one lands and when a sold-out compound is back — plus 15% off your first order, shown on screen the second you join.
Batch and restock notices from Synthrex Biotech LLC. No dosing advice, ever. One-click unsubscribe on every email.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.